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Crystal structure of Rab geranylgeranyltransferase at 
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Background: Rab geranylgeranyltransferase (RabGGT) catalyzes the addition
of two geranylgeranyl groups to the C-terminal cysteine residues of Rab
proteins, which is crucial for membrane association and function of these
proteins in intracellular vesicular trafficking. Unlike protein farnesyltransferase
(FT) and type I geranylgeranyltransferase, which both prenylate monomeric
small G proteins or short peptides, RabGGT can prenylate Rab only when Rab
is in a complex with Rab escort protein (REP).
Results: The crystal structure of rat RabGGT at 2.0 Å resolution reveals an
assembly of four distinct structural modules. The β subunit forms an α–α barrel
that contains most of the residues in the active site. The α subunit consists of a
helical domain, an immunoglobulin (Ig)-like domain, and a leucine-rich repeat
(LRR) domain. The N-terminal region of the α subunit binds to the active site in
the β subunit; residue His2α directly coordinates a zinc ion. The prenyl-binding
pocket of RabGGT is deeper than that in FT.
Conclusions: LRR and Ig domains are often involved in protein–protein
interactions; in RabGGT they might participate in the recognition and binding of
REP. The binding of the N-terminal peptide of the α subunit to the active site
suggests an autoinhibition mechanism that might contribute to the inability of
RabGGT to recognize short peptides or Rab alone as its substrate.
Replacement of residues Trp102β and Tyr154β in FT by Ser48β and Leu99β,
respectively, in RabGGT largely determine the different lipid-binding
specificities of the two enzymes.
Introduction
Many eukaryotic proteins are post-translationally modified
by the attachment of lipids [1,2]. For example, isoprenoid
C15 farnesyl and C20 geranylgeranyl (GG) groups are
found in numerous proteins including nuclear lamins,
trimeric G protein γ subunits, protein kinases, Ras, and
almost all Ras-related small GTP-binding proteins. The
isoprenoid groups are covalently attached via thioether
linkages to cysteine residues at or near the C terminus of
these proteins. Prenylation facilitates membrane associa-
tion and in some cases also plays a major role in specific
protein–protein interactions [3–5]. 
Protein prenyltransferases catalyze the transfer of the iso-
prenoids from either farnesyl diphosphate (FPP) or geranyl-
geranyl diphosphate (GGPP) to the cysteine residues of the
protein substrates. The protein prenyltransferase family
includes protein farnesyltransferase (FT), protein geranyl-
geranyltransferase type I (GGT-I) and Rab geranylgeranyl-
transferase (RabGGT or GGT-II) [6,7]. All protein
prenyltransferases are heterodimers consisting of α and
β subunits. FT and GGT-I are closely related and are often
collectively called ‘CaaX prenyltransferases’. Their α sub-
units are identical whereas their β subunits are distinct [8].
Both FT and GGT-I recognize a CaaX motif at the C ter-
minus of their protein substrates. This motif consists of a
cysteine residue that is modified in the reaction, two
aliphatic residues (aa) and a C-terminal residue X (where X
is any residue). In addition to the different preference for
the isoprenoid substrate, FT favours methionine, serine or
glutamine at the X position, whereas GGT-I prefers
leucine. [5,6]. FT and GGT-I can recognize short peptides
containing appropriate CaaX motifs as substrates [9–11]. 
Recently, the crystal structures of FT [12,13], as well as of
an FT–FPP complex [14] and of a ternary complex of FT
with the CaaX peptide acetyl–CVIM and the FPP ana-
logue α-hydroxyfarnesylphosphate [15] have been deter-
mined. These structures explained the selectivity of FT
for FPP and clearly showed the active site and the mode
of binding of the substrates, with the cysteine sulphur of
the bound peptide coordinating the active site zinc ion.
The structure of the ternary complex showed that several
sidechains in the active site of FT rearrange upon binding
of peptide and FPP analogue [15].
RabGGT is unique in the protein prenyltransferase family.
It exclusively modifies members of a single subfamily of
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Ras-related small GTPases, the Rab proteins [4,16]. Rab
proteins (molecular mass [Mr] ≈ 20–25 kDa) are involved
in the regulation of intracellular vesicular transport in the
biosynthetic secretory and exocytic/endocytic pathways
[17,18]. Most Rab proteins have a flexible tail with two cys-
teine residues at their C termini; the cysteines are arranged
in motifs such as -CC, -CXC, -CCX or -CCXX (in single-
letter amino acid and where X is any amino acid).
RabGGT catalyzes the transfer of two GG groups to the
two cysteines at the C terminus of Rab proteins [19]. The
enzyme does not recognize short peptides containing the
Rab C-terminal prenylation motif, nor does it recognize the
Rab protein alone [20,21]. The geranylgeranylation of Rab
requires the presence of Rab escort protein (REP,
Mr ≈ 72 kDa in mammals) [20,22]. The current view of the
prenylation cascade is as follows: newly synthesized Rab
binds REP and forms a stable Rab–REP complex with a
dissociation constant of 0.15–0.4 µM [20]. RabGGT recog-
nizes Rab–REP complexes as its protein substrate primar-
ily through interactions with REP [20]. After prenylation,
REP stays bound to the prenylated Rab and delivers Rab
to its target membrane [23,24].
Here we describe the crystal structure of RabGGT at
2.0 Å resolution. The structure differs from that of FT by
the addition of two discrete structural modules in the
α subunit. Residue substitutions in the GGPP-binding
pocket and the active site help to explain the functional
differences between FT and RabGGT.
Results and discussion
Structure of RabGGT
The asymmetric unit of RabGGT crystals contains two
molecules, related by local twofold symmetry; the two
molecules have almost identical structures. The overall
structure of RabGGT is shown in Figure 1a (see also
Figure S1, Supplementary material). The α subunit of
RabGGT is composed of three compact domains: a helical
domain, an immunoglobulin-like (Ig-like) domain and a
leucine-rich repeat (LRR) domain. The helical domain is
structurally similar to the α subunit of FT with a root
mean square deviation (rmsd) of 2.1 Å between 216 super-
imposable Cα positions in the two proteins. A structure-
based alignment (Figure 2a) shows only 22% sequence
identity between FTα and RabGGTα. The 15 helices in
Figure 1
Ribbon representation of the RabGGT
structure (cyan, helical domain of the
α subunit; orange, Ig-like domain; green, LRR
domain; purple, β subunit; blue, 310 helices of
all domains). (a) Complete structure of
RabGGT. (b) The helical domain and LRR
domain of RabGGTα in a slightly different
orientation from (a). The 15 helices are
numbered from α1 to α15. (c) The Ig-like
domain of RabGGTα. The strands are labelled
according to the convention in [34].
(d) The β subunit of RabGGT, with the zinc
ion shown as a red ball and the ligands
Asp238β, Cys240β and His290β in ball-and-
stick representation. The helices are
numbered β1–β14.
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the helical domain (α1 to α15; Figure 1b) form a crescent-
shaped right-handed superhelix. A similar fold has been
found in several other proteins including lipovitellin
[25,26], bacterial muramidase [27], and more recently in
the tetratricopeptide repeat (TPR) region of protein phos-
phatase 5 [28]. Most likely, an evolutionary relationship
exists between the repeat sequences in prenyltransferase
α subunits and those in TPRs [29].
The presence of an Ig-like domain and an LRR domain
in the α subunit distinguish RabGGT from FT and
GGT-I. The Ig-like domain comprises residues 244α to
345α and is folded into an eight-stranded β sandwich
(Figure 1c). All eight cysteine residues of the domain are
in the reduced state. The domain is inserted between
helices α11 and α12, and connected to the helical domain
by two loops the high B factors of which  indicate flexi-
bility. One face of the domain (strands h, a, b, e) is packed
against the LRR domain. The Ig-like domain has few
other intramolecular contacts but interacts with three
neighbouring molecules in the crystal; this suggests that
the observed orientation is, at least in part, determined
by crystal contacts. A DALI search [30] for structures
similar to the Ig-like domain gives Z-scores of 6.4 for 
β-galactosidase domain 4 [31], 6.2 for the CH2 domain
(residues 238–338) of an IgG crystallizable fragment (Fc)
[32], and 3.4 for the C2 domain of synaptotagmin [33].
The sequence identity between 86 aligned residues in
the RabGGT Ig-like domain and domain 4 of β-galactosi-
dase is 19% (Figure 2b), indicating that these two
domains might be evolutionarily related. Without the
eighth strand, the Ig-like domain in RabGGTα would
belong to the h-type immunoglobulin fold [34].
The second additional domain, the LRR domain, com-
prises residues 443α to 567α, including the C terminus of
the α subunit (Figure 1b). The sequence of this domain
contains five LRRs with lengths varying from
22–27 residues (Figure 2c). The LRR domain folds into a
right-handed superhelix of alternating β strands and 310
helices (α helix in the last repeat); the axis of the super-
helix is slightly curved towards the β-sheet side. The con-
formation of each individual LRR unit is similar to that
observed in porcine ribonuclease inhibitor (PRI) [35].
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Figure 2
Structure-based sequence alignments. Elements of secondary
structure are indicated by coloured boxes. The colour scheme used is
the same as in Figure 1. (a) RabGGTα helical domain against FTα.
(b) RabGGTα Ig-like domain against domain 4 in β-galactosidase
(1BGL). (c) RabGGTα LRR domain against U2A′LRR (1a9n). Two
LRRs with lengths of 28 and 29 residues each from porcine
ribonuclease inhibitor (2bnh) are also aligned. The LRR consensus
sequence motif is show at the bottom. (d) RabGGTβ against FTβ.
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Especially the β-strand regions and the αα, αβE, and βPγ
turns (nomenclature as in [35]) of the two structures
superimpose well, except for the last repeat (Figure 3a).
With an average length of 24 residues the LRR units in
the RabGGT LRR domain are shorter than those in PRI
(28–29 residues per repeat), and represent the most popu-
lated subfamily of LRRs [36,37]. Extended loops, fol-
lowed by short 310 helices, substitute for the longer helical
regions found in PRI; this causes the superhelix of the
RabGGT LRR domain to be less curved than in PRI.
Recently, the three-dimensional structure of another
LRR-containing protein, the spliceosomal U2A′LRR in
complex with U2B′′ and a fragment of U2 RNA [38], was
determined. Like the RabGGT LRR domain, U2A′LRR
contains five typical LRRs, and their overall structures are
very similar as indicated by an rmsd of 1.2 Å over 116
superimposable Cα positions (Figure 3b). Remarkably,
the last repeat, which has a conformation rather different
from the rest of the repeats, adopts very similar conforma-
tions in the two structures. The N-terminal helix flanking
the first LRR in U2A′LRR is also in approximately the
same place as helix α15 in RabGGT (Figure 3b). The
hydrophobic face of helix α15 of RabGGT is packed
tightly against the hydrophobic interior of the LRR
domain at the N-terminal end (Figure 1b). This suggests
that the position of the LRR domain is fixed relative to
the helical domain of RabGGTα.
The β subunit of RabGGT contains an α–α barrel made
up of 12 α helices (Figure 1d); it is very similar to the α–α
barrel in the β subunit of FT [12] with an rmsd of 1.4 Å
between 280 superimposable Cα positions. With 30%
identity (Figure 2d), the sequences of the β subunits of
FT and RabGGT are more conserved than those of their
α subunits. The α–α barrel fold has also been observed in
other protein structures, including squalene–hopene
cyclase [39], complement component C3d [40] and
endoglucanase [41]. The β subunit in RabGGT is smaller
than the β subunit in FT (331 residues in RabGGTβ
versus 437 residues in FTβ). It lacks the first α helix and
the C-terminal long loop compared with FTβ. The centre
of the α–α barrel forms a funnel-shaped pocket lined with
mostly aromatic residues. The bottom of this barrel is
blocked by a turn, followed by a short α helix near the
C terminus of the β subunit, whereas the top of the
barrel is open. The crescent-shaped helical domain in
RabGGTα embraces the β subunit around half its circum-
ference close to the open end of the barrel (Figure 1a),
whereas the Ig-like and LRR domains do not make con-
tacts with the β subunit. The 310 helix side of the LRR
domain and the bottom of the α–α barrel of the β subunit
form a pronounced groove (Figure 1a; see also Figure S2,
Supplementary material).
Zinc-binding site
The first direct evidence for the presence of an intrinsic
zinc ion in RabGGT was the observation of the zinc edge
in the X-ray absorption spectrum of a RabGGT crystal
(data not shown). Anomalous difference Fourier maps
showed the location of the zinc ion in the β subunit, where
it is coordinated by Asp238β, Cys240β and His290β
(Figure 4) in a fashion similar to that observed in FT. The
fourth ligand of the zinc ion is residue His2α of the same
RabGGT molecule (Figure 4). The N-terminal region of
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Figure 3
Comparison of RabGGT LRR domain with other LRR
structures. (a) Superposition of one LRR unit from RabGGT (shown in
green) with one from PRI (shown in yellow). The positions are marked
as in the consensus sequence described in [35]. (b) Stereoview Cα
trace of the RabGGT LRR domain superimposed with U2A′LRR [38].
RabGGT is coloured green and U2A′LRR is coloured orange. The first
and last residues of each domain are labelled.
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the α subunit binds to the β subunit in an extended con-
formation with His2α coordinating the zinc ion, and
Lys6α forming an ionic interaction with Asp272β. It also
contacts residues 283β–285β, which are part of the long
loop connecting helices β12 and β13. The N termini of
both α and β subunits in RabGGT are modified
(M Seabra, unpublished observations), and the density at
the N terminus of the α subunit can be modelled as a
formylated methionine (Figure 4).
In the crystals of unliganded FT the C-terminal region of
a neighbouring β subunit binds to the active site [12].
This intermolecular interaction is most probably because
of crystal packing because it does not involve the catalytic
zinc ion and is absent in the isomorphous crystals of an
FT–FPP complex [14]. In contrast, the interaction
between the N-terminal region and the active site in
RabGGT includes direct binding of His2α to the zinc ion,
and is intramolecular. The high B factors and poorly
defined density of residues 8–26α indicate that the con-
nection between the N-terminal region of RabGGTα and
the main body of the α subunit is mobile, so that it can
move out of the way upon binding of substrate peptide.
The binding of the N-terminal region to the active site
might be autoinhibitory and prevent binding of short sub-
strate peptides to RabGGTα.
Comparison of the peptide-binding sites of FT and RabGGT
A superposition of the RabGGT active site with both unli-
ganded and liganded FT is shown in Figure 5. In the crystal
structure of the complex of FT with substrates [15] the cys-
teine sulphur of the bound CVIM peptide coordinates the
active site zinc ion. The hydrophobic sidechains of
isoleucine and methionine are in the pocket lined with the
FT sidechains of Trp102β, Trp106β, Tyr361β, His149β,
Ala151β and Pro152β; the isoleucine sidechain is also in van
der Waals contacts with the FPP isoprenoid. The main-
chain of the bound peptide interacts with FT as well: the
isoleucine carbonyl oxygen forms a hydrogen bond with the
guanidinium group of Arg202β, and the terminal carboxy-
late interacts with Gln167α. The sidechains of some active-
site residues, including Tyr166α, Arg202β and Glu198β,
adopt different conformations in unliganded FT [12] and in
FT with bound peptide and lipid substrates [15]. 
Several residues in the peptide substrate binding pockets
of FT and RabGGT are different (Figure 5); these residues
are highly conserved within members of the FT and
RabGGT families. Ala151β and Pro152β in FT form part of
the pocket that accommodates the methionine sidechain of
the bound CVIM peptide; they are changed to leucine 96β
and Tyr97β in RabGGT, respectively, which would clash
with the methionine sidechain (Figure 5). Gln167α in FT,
which forms a hydrogen bond with the carboxylate of the
bound CVIM peptide, is replaced with Gly108α in
RabGGT. In addition, sidechains of Tyr107α and Glu140β
in RabGGT adopt conformations drastically different from
those of the corresponding residues Tyr166α and Glu198β
in the unliganded FT; their conformations are more similar
to those in the FT–substrate complex (Figure 5). 
These structural differences between the active sites of FT
and RabGGT weaken the interactions between the
tetrapeptide and RabGGT. Further reasons for the inability
of RabGGT to bind and prenylate cysteine-containing
tetrapeptides or monomeric Rab proteins might be the
positions of cysteines at, or 1–2 residues away from, the C
terminus of most Rab proteins. As the cysteine must bind to
the zinc ion, only 0–2 additional residues are interacting
with the enzyme. For the intramolecular interaction of the
N-terminal region of the α subunit with the active site to be
disrupted and replaced, substrate in high local concentra-
tion is needed. Such a high local substrate concentration is
likely to exist in the complex of Rab–REP with RabGGT.
Prenyl-binding site
The α–α barrel of the RabGGT β subunit contains a
central cavity that is lined with several hydrophobic
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Figure 4
Electron density and atomic model in around the active site with the
zinc ion and its protein ligands. The map was calculated with SIGMAA-
weighted 2Fo–Fc coefficients and final model phases; the contour level
is at 1σ.
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residues including Trp52β, Phe147β, Tyr195β, Trp243β,
Trp244β, Phe289β and Phe293β. A positively charged
cluster formed by Arg232β, Lys235β and Lys105α is
located near the opening of the cavity, close to the inter-
face with the α subunit, and about 9 Å from the active site
zinc ion. Both the hydrophobic cavity and the positively
charged cluster are also present in FT. In the structure of
the FT–FPP complex [13,14], the FPP binds with its
hydrophobic tail to the interior of the cavity and with the
diphosphate head group to the positively charged cluster.
Residues from the α subunit also contribute to the
diphosphate-binding site.
The most noticeable difference between the prenyl-
binding cavities of FT and RabGGT is the substitution of
residues Trp102β and Tyr154β of FT by residues Ser48β
and Leu99β in RabGGTβ. This leads to a significantly
wider and deeper cavity in RabGGT (Figure 6a). We have
modelled a GGPP molecule in the pocket at a position
similar to that observed in the structure of the FT–FPP
complex [13,14], with the diphosphate moiety near the
positively charged cluster and the tail of the GG group near
Leu99β (Figure 6b). A tyrosine residue at position 99β
would clash with the modelled GGPP tail, whereas a tryp-
tophan at position 48β does not seem to interfere. It is pos-
sible, therefore, to model GGPP with two slightly different
conformations: one conformation would have the GG tail
near Ser48β, and the other would have the tail near
Leu99β. A multiple alignment shows that in the GGT-Iβ
sequence family, the tyrosine at the position corresponding
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Figure 5
Stereo diagram of RabGGT active site,
superimposed with substrate-free FT ([12],
PDB code 1FT1), and FT–substrate ternary
complex ([15], PDB code 1QBQ). RabGGT is
coloured magenta; substrate-free FT, green;
liganded FT, blue; FPP, gray; and the peptide
substrate, red. Selected residues of
unliganded FT are labelled.
Figure 6
Prenyl-binding pocket. (a) Comparison of the
prenyl binding pockets of RabGGT (magenta)
and FT (green). The sidechains of several
relevant residues are shown in ball-and-stick
representation. Residues W102β and Y154β
of FT are labelled; these residues correspond
to S48β and L99β of RabGGT, respectively.
(b) Surface representation of the GGPP-
binding pocket of RabGGT with a
hypothetical GGPP model. Key residues
determining the size of the pocket and the
phosphate-binding site are labelled. The
peptide-binding site, including the zinc ion, is
cut away for clarity.
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to Tyr154β in FT is conserved, whereas the residue corre-
sponding to Trp102β in FT is replaced by smaller residues
such as aspartic acid or serine (data not shown). In the
RabGGT family, both positions are occupied by smaller
residues. The distinct conservation pattern at these two
positions might serve as a signature for the three protein
prenyltransferase subfamilies. 
Two other highly conserved residues in FT or GGT-I α
subunits, Tyr131α and Gln167α, are Ala63α and Gly108α,
respectively, in RabGGTα. These two residues are
located at the interface of the α and β subunit near the
lipid-binding site. The role of these two residues remains
to be examined.
The double prenylation mechanism
Previous studies on mammalian FT indicate that farnesy-
lation proceeds via an ordered sequential mechanism
[42,43]. FT first binds FPP, which then reacts with the
peptide substrate to form the product. The product
release is the rate-limiting step in this sequence [44]. After
prenylation, the sulphur atom of the produced thioether
remains coordinated to the metal ion in the FT
enzyme–product complex [45], and the prenylated
peptide product does not dissociate from the enzyme
unless additional substrate is provided [46].
A recent study showed that RabGGT, like GGT-I, pos-
sesses a single GGPP-binding site, despite the fact that
the enzyme catalyzes double GG transfer [47]. Consistent
with this result, there is only one positively charged
cluster that could bind a diphosphate moiety in the
RabGGT crystal structure, although the lipid-binding
pocket could accommodate GG groups in alternative con-
formations. Residues Tyr241β and Lys105α are likely to
play a crucial role in the correct positioning of the first and
the second phosphate and thus of the GGPP C1 atom near
the protein substrate thiol for the subsequent nucleophilic
attack. Mutations of the two corresponding residues,
Tyr310β of yeast FT and Lys164α of rat FT, completely
abolished enzyme activity [48,49]. 
Two possible scenarios could occur after the first GG
transfer is accomplished. First, the monoprenylated
product could remain bound to the enzyme, and the
diphosphate head group dissociates from the active site.
As soon as the diphosphate-binding site becomes vacant,
a second GGPP might be able to bind to the enzyme. The
conversion of a thiolate-S ligand to a more weakly bound
thioether-S ligand might drive ligand reorganization at the
metal centre, in which the other free cysteine at the Rab
C terminus might become liganded to the zinc and ready
for the second prenylation reaction. Another scenario is
that after the first prenylation, the monoprenylated
peptide dissociates from the active centre temporarily,
but because the catalytic ternary complex is still intact
through interactions between RabGGT and the
Rab–REP complex, the dissociated peptide could bind to
the active site again for the second prenylation. In both
scenarios, rearrangement of the C-terminal peptide of Rab
after the first prenylation has to take place for prenylation
of the second cysteine. This requires less specific and
more flexible binding of the peptide in RabGGT than in
FT and explains the necessity for recognition and binding
between Rab and RabGGT at other sites. 
The most striking difference between RabGGT and FT
or GGT-I is the presence of two additional domains in the
α subunit, the Ig-like domain and the LRR domain. Both
domains appear in many proteins and mostly participate in
protein–protein interactions [34,50]. In RabGGTα the
two domains could provide part of the necessary interac-
tions with Rab proteins for the double prenylation to
proceed. Both the Ig-like domain and the LRR domain
are located opposite from the active site, however, so that
Rab with its C terminus bound to the active site of
RabGGT could not make contact with either domain. The
observation that Rab has to form a complex with REP
before binding to RabGGT [20] suggests that REP is
likely to make this contact. 
In addition, a different kind of steric restraint might
prevent Rab from interacting with RabGGT directly: the
source of cellular GGPP is probably either a membrane
pool or GGPP synthetase. In order to be able to take up
lipid before and during double prenylation, RabGGT
needs to keep its active site accessible for contacts with
either the membrane or GGPP synthetase. This might be
another reason why Rab itself does not form contacts with
RabGGT near the active site, and requires to form the
Rab–REP complex in order to interact with RabGGT at
sites remote from the active site.
REP is structurally and functionally related to another
Rab-binding protein, Rab GDP dissociation inhibitor
(RabGDI) [4,51]. RabGDI is postulated to extract Rab
proteins from acceptor membranes, and to recycle them
through the cytosol back to donor membranes [17,18].
The three-dimensional structure of RabGDI is similar to
that of FAD-dependent flavoproteins [51]. There is no
indication that RabGDI binds FAD, however, and the
region equivalent to the FAD-binding pocket is a
shallow groove. It is possible that the digeranygeranyl
groups bind to this groove. Given the high similarity
between RabGDI and REP, we assume that they inter-
act similarly with Rab proteins. Compared with RabGDI,
REP has an insertion of ~140 amino acids in the middle
of the protein and about 70 more residues at the C termi-
nus. These additional regions might mediate the inter-
action of REP with RabGGT; they might also contribute
to the binding of both prenylated and unprenylated
forms of Rab proteins by REP.
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From the protein sequences available so far, it can be seen
that the Ig-like and LRR domains are present only in the
α subunits of RabGGTs from mammals, Arabidopsis
thaliana and Caenorrhabitis elegans, but not in those of
yeast. Also, the yeast counterpart of REP does not contain
the unique 140 amino acid insert [52]. This suggests that
the interaction between REP or the REP–Rab complex
with the enzyme in yeast might be distinct from that in
the higher eukaryotes. 
Identification of the potential binding regions in the
enzyme and protein substrate might have implications
beyond mechanistic insights into the prenylation reaction.
Defects in Rab prenylation are the cause of the retinal
degenerative disease choroideremia [22,53]. The disease
is caused by loss-of-function mutations in REP1, which is
one of the two known human REP genes, REP1 and
REP2. The phenotype is restricted to the retina because
REP1 function is compensated in most cell types by the
closely related REP2 [54]. In choroideremia cells, in
which only REP2 is active, one Rab (Rab27) remains
selectively unprenylated. It appears, therefore, that the
molecular defect is an inability to prenylate efficiently a
specific substrate of RabGGT, namely the REP2–Rab27
complex [55,56]. This could be because of a low affinity
REP2–Rab27 interaction or a low affinity of the complex
for the enzyme. The crystal structure of RabGGT repre-
sents the first step towards understanding the recognition
of REP–Rab and the complex mechanism of double
prenylation catalyzed by RabGGT. This will lead to
understanding of the molecular defect in choroideremia.
Biological implications
Rab geranylgeranyl transferase (RabGGT) is unique in
the protein prenyltransferase family because it recog-
nizes only a Rab–Rab escort protein (REP) complex as
its protein substrate, and because it catalyzes double
prenylation of Rab. The structure of RabGGT reveals
an unusual architecture of four distinct domains, each
with a different fold. The β subunit is the major catalytic
component; it is composed of an α–α barrel fold, which
has been found in several other enzymes, among them
protein farnesyltransferase (FT). The α subunit consists
of three domains: an α-helical domain structurally
similar to the α subunit of FT; an immunoglobulin-like
domain; and a leucine-rich repeat domain. Most likely,
these additional domains are involved in the recognition
of the REP–Rab complex, especially in the interaction
with REP, and perhaps with other proteins as well.
The high-resolution structure of RabGGT provides
details of the active site and the substrate-binding pockets
that enable us to gain new insights into the substrate-
binding specificity and, in particular, the double prenyla-
tion mechanism. The substitution of residues Trp102β
and Tyr154β of FT by residues Ser48β and Leu99β in
RabGGT is probably the main determinant of the differ-
ent prenyl binding specificity of the two enzymes. The
presence of only one possible diphosphate-binding site
suggests that the binding and the correct positioning of
the second geranylgeranyl diphosphate can only occur
after the dissociation of the first diphosphate group. The
N-terminal region of the α subunit binds to the active site
in the β subunit in an autoinhibitory fashion. The
RabGGT structure reported here suggests further bio-
chemical and mutagenesis studies of the interaction of
RabGGT with the REP–Rab complex, of the double
prenylation mechanism and of the functional role of
autoinhibition.
Materials and methods
Protein expression and purification
RabGGT was expressed in Sf9 cells co-infected with baculovirus
encoding the α and the β subunit, and partially purified using ion
exchange chromatography (Q-Sepharose, Pharmacia) and gel filtration
(Superdex 200, Pharmacia), as described previously [54,57]. To obtain
highly purified and homogeneous protein suitable for crystallization
experiments, RabGGT was further subjected to ion exchange and
hydrophobic interaction chromatography. The pooled RabGGT frac-
tions from the Superdex 200 column were loaded on a Mono Q
HR10/10 column (Pharmacia) equilibrated with 50 mM Bis-Tris
(pH 6.5), 150 mM NaCl and 1 mM DTT. The protein was eluted using a
160 ml linear gradient of 150–350 mM NaCl. Next 4 M (NH4)2SO4
was added to the pooled RabGGT fractions until the final concentra-
tion of (NH4)2SO4 was 0.6 M. This material was loaded on a Phenyl
Superose HR10/10 column (Pharmacia) that had been equilibrated in
buffer containing 50 mM Hepes (pH 7.2), 0.6 M (NH4)2SO4 and 1 mM
DTT. The column was then washed with a 80 ml gradient of
0.6–0.24 M (NH4)2SO4. The protein was concentrated to 15 mg/ml,
frozen in liquid nitrogen and stored at —80°C in a buffer containing
20 mM Hepes (pH 7.2), 20 mM NaCl, 10 mM MgCl2, 10 mM NaH2PO4
and 5 mM DTT. Usually 5–10 mg pure RabGGT were obtained from 1 l
of Sf9 cell culture.
Protein crystallization
RabGGT crystals were grown by the hanging drop vapor diffusion
method at 21°C. A 2 µl aliquot of 5–10 mg/ml of RabGGT in storage
buffer was mixed with 2 µl precipitant solution (0.1 M Na-acetate,
0.25 M Mg-acetate, 10 mM NaH2PO4, 6% ethylene glycol and
17–21% PEG8000, pH 5.5) and equilibrated against a reservoir con-
taining 0.7 ml precipitant solution. Crystals usually appeared overnight
and reached a maximum size of 0.7 mm × 0.3 mm × 0.1 mm in one
week. The crystals have the symmetry of space group P1 with two mol-
ecules in the asymmetric unit. Unit-cell dimensions are a = 57.86 Å,
b = 77.44 Å, c = 121.78 Å, α = 74.60°, β = 79.91° and γ = 67.89°. The
solvent content of the crystals is 42%. After having grown for
8–10 days, the crystals were harvested in a stabilization solution (0.1 M
BES, 0.25 M Mg-acetate, 15% PEG8000, 3% ethylene glycol, pH 7.2)
for heavy-atom derivatization. Before collecting X-ray diffraction data,
crystals were cryoprotected in stabilization solution supplemented with
5–30% PEG400, mounted on cryoloops (Hampton, Riverside, CA)
and frozen in liquid propane.
X-ray data collection and structure determination
X-ray diffraction data were collected on an Raxis IIC image plate system
with graphite-monochromatized CuKα X-rays produced by a Rigaku RU-
300 generator, and on a nine-element CCD detector at beamline 19ID
at the Advanced Photon Source (APS), Argonne National Laboratory.
The synchrotron data were collected at a wavelength of 1.0084 Å. All
X-ray diffraction data were measured at –180°C. Raw images were
processed using the HKL package [58]. The conventional heavy-atom
derivatized crystals were prepared by soaking the crystals in the stabi-
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lization solution containing heavy atom compounds for various periods
of time. Xenon-derivatized crystals were prepared in a specially
designed xenon chamber (courtesy of Z Wang) following a procedure
similar to that described by [59]: a RabGGT crystal was mounted on the
cryoloop after cryoprotection, and was inserted into the xenon pressure
cell containing a drop of the cryoprotectant solution to maintain humid-
ity. The cell was then pressurized with 300 psi xenon gas for 10–20 min
after which the crystal was quickly frozen in liquid propane within a few
seconds of complete depressurization.
The RabGGT structure was determined by a combination of multiple
isomorphous replacement (MIR) and molecular replacement (MR)
techniques. A model containing a total of 524 polyalanine residues
derived from the crystal structure of farnesyltransferase [12] was used
as a search model. A molecular replacement solution was found using
the program AMORE [60] of the CCP4 package [61]. The following
four heavy-atom derivatives were used in MIR phasing (Table 1):
K3IrCl6, Hg(SCH2CH2COONa)2, di-iodobis-ethylenediamine-diplat-
inum(II) nitrate (PIP) and xenon. The heavy-atom sites for the Ir and
xenon derivatives were found in both isomorphous and anomalous dif-
ference Patterson maps, whereas the sites in the Hg and PIP deriva-
tives were found only by difference Fourier methods. The phases from
the MR solution were used to locate heavy-atom sites in the four deriv-
atives and to bring them to the same origin, but were not combined
with the resulting MIR phases. The heavy-atom parameters were
refined and MIR phases were calculated using the program
MLPHARE [61,62]. The final figure of merit was 0.39 for date up to
2.5 Å resolution. The phases were significantly improved by twofold
molecular averaging, solvent flattening and histogram matching using
the program DM [61,63].
Model building and refinement
The density modified MIR map was readily interpretable and an atomic
model was build into the density at 2.5 Å resolution using the program O
[64]. The refinement was monitored by the Rfree [65] computed with 5%
of the data randomly selected and removed from the refinement. All
steps of the following refinement were done including all low-resolution
data and with a bulk-solvent correction. Initially, a strong noncrystallo-
graphic symmetry (NCS) restraint was applied to the two molecules in
the asymmetric unit. The initial model with an R factor of 0.47 was first
refined using the program REFMAC [66] with an overall B-factor refine-
ment using data up to 2.5 Å resolution. This led to a drop of Rwork to 0.37
and Rfree to 0.42. This model was then subjected to a simulated anneal-
ing procedure in CNS_0.3 [67] followed by grouped B-factor refinement
and individual B-factor refinement. This led to an improvement of Rwork to
0.30 and Rfree to 0.37. Several rounds of manual rebuilding followed by
restrained refinement in REFMAC reduced R factors to 0.27 for Rwork
and 0.31 for Rfree. At this point all data up to 2.0 Å resolution were
included in the refinement. It became clear that certain regions in the two
molecules deviate from the strict NCS, and the NCS restrains were thus
abandoned. Further refinement and rebuilding resulted in Rwork/Rfree to
be 0.25/0.30, respectively. At this stage, solvent molecules were gradu-
ally included in the model using the WATERPICK routine in CNS. The
final model contains the complete α subunit (residues 1–567) and 329
residues (residues 3–331) of the β subunit. Several loop regions have
high B factors approaching 100 Å2, indicating disorder. These regions
include residues 8α to 25α, 192α to 199α, and 33β to 39β. Refinement
statistics are summarized in Table 2.
Accession numbers
Refined atomic coordinates of RabGGT have been deposited with the
Protein Data Bank under accession code 1DCE.
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Table 1
Crystal data and phasing statistics.
Native I* Native II† Xe derivative† Ir derivative* Pt derivative* Hg derivative*
Resolution limits (Å) 2.0 2.25 2.6 2.5 2.5 2.5
Rsym‡ 0.063 (0.58) 0.062 (0.50) 0.098 (0.34) 0.051 (0.19) 0.071 (0.69) 0.072 (0.28)
Observations 446,152 144,448 187,269 268,007 218,699 244,124
Unique reflections 118,808 78,800 54,221 63,630 61,166 64,091
Completeness (last shell) 93.4 (86.1) 86.5 (55.1) 93.2 (63.9) 97.9 (92.3) 92.9 (80.8) 98.1 (94.0)
<I>/σ(I) (last shell) 23.2 (2.33) 10.9 (2.01) 17.7 (4.12) 30.6 (7.61) 17.9 (1.44) 22.4 (4.15)
Heavy-atom concentration – – 300 psi 10 mM sat. 5 mM
Soak time (h) – – 0.2 2.5 3 0.5
Number of sites – – 5 9 6 8
∆F/F§ – – 0.20 0.24 0.20 0.24
FH/E# – – 0.75 0.64 0.61 0.60
Rcullis¶ – – 0.90 0.92 0.92 0.93
<FOM>¥ 0.389
*Data were collected at APS, Argonne National Laboratories, Beamline
19ID. †Data were collected on RAXIS-II image plate with Rigaku
RU300 rotating-anode generator. ‡Rsym = ΣjIj – <Ij>/ Σj Ij, where
<Ij> is the average intensity of reflection j for its symmetry equivalents;
values in parentheses are for the highest resolution shell.
§∆F/F = ΣjFPH – FP / Σj FP, where FPH and FP are the derivative and
native structure-factor amplitudes, respectively.
#FH/E = ΣjFH2 / ΣjE2 in the phasing power of the derivative; FH is
the calculated heavy-atom structure-factor amplitude and E is the lack
of closure error. Phases were calculated to 2.5 Å resolution.
¶Rcullis = ΣjFPH ± FP = FH / ΣjFP ± FH. ¥<FOM> is the mean
figure of merit.
Table 2
Refinement statistics.
Resolution range (Å) 20–2.0
Number of reflections 118,808
Rcryst (%) 21.8
Rfree (%) 26.3
Protein atoms 14,185
Zinc atoms 2
Water molecules 830
Rmsd bond lengths (Å) 0.016
Rmsd bond angles (°) 1.8
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Supplementary material
Supplementary material including a stereoview Cα trace of RabGGT
and a stereoview of the molecular surface of RabGGT is available at
http://current-biology.com/supmat/supmatin.htm.
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